/PRNewswire/ Madison River Capital ("MRC"), a lower middle market private equity firm focused on partnering with and building leading businesses across a.
/PRNewswire/ CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, today announced the acquisition.
/PRNewswire/ Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today presented its 2024 business.